Mirum Pharmaceuticals, Inc. (MIRM) Earnings
|
Expand Research on MIRM
| Next EPS Date | 11/17/26 | EPS Growth Rate | -1,160.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -924.1% | Revenue Growth Rate | +33.9% |
| Average % Move 1-Wk after EPS | +3.9% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/26  |
Q326 | N/A | -$0.53 | N/A | N/A | $178.06M | = | N/A | N/A | ||
| 8/5/26 |
Q226 | -$1.06 | -$0.74 | -$0.32 | $176M | $166.03M | = |  | | Details | |
| 5/6/26 | Q126 | -$13.43 | -$0.34 | -$13.09 | $159.9M | $148.8M | = | | | Details | |
| 5/1/26 |
Q126 | N/A | -$0.34 | N/A | N/A | $148.8M | = | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.34 | N/A | N/A | $148.8M | = | N/A | N/A | ||
| 2/25/26 |
Q425 | N/A | -$0.02 | N/A | N/A | $138.89M | = | N/A | N/A | ||
| 11/4/25 | Q325 | $0.05 | -$0.15 | +$0.20 | $133.01M | $130.11M | = | | | Details | |
| 8/6/25 | Q225 | -$0.12 | -$0.33 | +$0.21 | $127.78M | $107.36M | = | | | Details |
